Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Designer Babies and 23andMe
23andMe recently was awarded a patent for a technique that could be used to create babies with selected traits. (For more on this, click here.) Do you think this new technology will be used solely to prevent diseases like Down syndrome, or has a Brave New World of selecting children’s physical traits (eye color, sex, etc.) come upon us?